Canagliflozin Helps Heart, Kidneys in ' Well-Controlled ' Diabetes Canagliflozin Helps Heart, Kidneys in ' Well-Controlled ' Diabetes

A subanalysis of CREDENCE suggests that SGLT2 inhibitor use should be based on clinical benefit, not solely glycemic control, say researchers. Another study hints that these drugs up EPO levels.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news